Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | POLYMER SCIENCE//CHEMISTRY, PHYSICAL//MATERIALS SCIENCE, MULTIDISCIPLINARY | 1554940 |
| 177 | 3 | ELECTROSPINNING//MATERIALS SCIENCE, BIOMATERIALS//POLYHYDROXYALKANOATES | 57028 |
| 280 | 2 | POLYLACTIC ACID//POLYLACTIDE//MATERIALS SCIENCE, BIOMATERIALS | 19116 |
| 27187 | 1 | IN SITU FORMING IMPLANT//INTRATUMORAL DRUG DELIVERY//CANC TARGETED DRUG DELIVERY | 255 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | IN SITU FORMING IMPLANT | authKW | 2032798 | 10% | 66% | 25 |
| 2 | INTRATUMORAL DRUG DELIVERY | authKW | 565000 | 3% | 57% | 8 |
| 3 | CANC TARGETED DRUG DELIVERY | address | 494381 | 2% | 100% | 4 |
| 4 | BENZYL BENZOATE BB | authKW | 370785 | 1% | 100% | 3 |
| 5 | SUSTAINED RELEASE DEPOT | authKW | 370785 | 1% | 100% | 3 |
| 6 | IN SITU FORMING GEL | authKW | 356237 | 3% | 41% | 7 |
| 7 | IN SITU IMPLANT | authKW | 329584 | 2% | 67% | 4 |
| 8 | SAIB | authKW | 282500 | 2% | 57% | 4 |
| 9 | IN SITU FORMING SYSTEM | authKW | 278088 | 1% | 75% | 3 |
| 10 | DUAL RELEASE KINETICS | authKW | 247190 | 1% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 2407 | 56% | 0% | 143 |
| 2 | Materials Science, Biomaterials | 1306 | 12% | 0% | 31 |
| 3 | Engineering, Biomedical | 592 | 13% | 0% | 32 |
| 4 | Chemistry, Multidisciplinary | 356 | 26% | 0% | 66 |
| 5 | Chemistry, Medicinal | 290 | 11% | 0% | 27 |
| 6 | Polymer Science | 225 | 12% | 0% | 31 |
| 7 | Toxicology | 28 | 4% | 0% | 10 |
| 8 | Literature | 27 | 2% | 0% | 4 |
| 9 | Food Science & Technology | 11 | 4% | 0% | 9 |
| 10 | Medicine, Research & Experimental | 4 | 3% | 0% | 7 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANC TARGETED DRUG DELIVERY | 494381 | 2% | 100% | 4 |
| 2 | PHARMACEUT INTELLIGENCE UNIT PRACHOTE PLENGWITTAY | 222469 | 1% | 60% | 3 |
| 3 | CLIN EXPTL PHARMACOL | 123595 | 0% | 100% | 1 |
| 4 | CLIN USE UNIT | 123595 | 0% | 100% | 1 |
| 5 | HEILONGJIANG PROV CORP HOSP | 123595 | 0% | 100% | 1 |
| 6 | HOSP ZIBO CITY 1 | 123595 | 0% | 100% | 1 |
| 7 | ONKOL THER IEFOR | 123595 | 0% | 100% | 1 |
| 8 | PHARMACEUT SCI MED PROD INNOVAT POLYMERS | 123595 | 0% | 100% | 1 |
| 9 | PHARMACEUT SCIWEST CHINA PHARM | 123595 | 0% | 100% | 1 |
| 10 | POLYMER SCI SYNTH | 123595 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CONTROLLED RELEASE | 17423 | 13% | 0% | 33 |
| 2 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 4602 | 5% | 0% | 12 |
| 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 4343 | 9% | 0% | 24 |
| 4 | SCIENCE-FICTION STUDIES | 3182 | 2% | 1% | 4 |
| 5 | JOURNAL OF PHARMACEUTICAL SCIENCES | 3132 | 7% | 0% | 17 |
| 6 | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY | 2099 | 2% | 0% | 5 |
| 7 | JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A | 1684 | 4% | 0% | 9 |
| 8 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1585 | 3% | 0% | 7 |
| 9 | DRUG DELIVERY AND TRANSLATIONAL RESEARCH | 1442 | 1% | 1% | 2 |
| 10 | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1411 | 3% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |